Cubist Systematic Strategies’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,000
| Closed | -$42K | – | 3775 |
|
|
2022
Q3 | $42K | Sell |
18,000
-2,975
| -14% | -$6.94K | ﹤0.01% | 3353 |
|
|
2022
Q2 | $64K | Buy |
20,975
+8,484
| +68% | +$25.9K | ﹤0.01% | 3516 |
|
|
2022
Q1 | $85K | Buy |
12,491
+5,294
| +74% | +$36K | ﹤0.01% | 3258 |
|
|
2021
Q4 | $60K | Sell |
7,197
-4,380
| -38% | -$36.5K | ﹤0.01% | 3285 |
|
|
2021
Q3 | $86K | Sell |
11,577
-19,555
| -63% | -$145K | ﹤0.01% | 2769 |
|
|
2021
Q2 | $212K | Buy |
31,132
+3,279
| +12% | +$22.3K | ﹤0.01% | 2521 |
|
|
2021
Q1 | $286K | Buy |
+27,853
| New | +$286K | ﹤0.01% | 2282 |
|
|
2020
Q4 | – | Sell |
-54,172
| Closed | -$442K | – | 2765 |
|
|
2020
Q3 | $442K | Buy |
+54,172
| New | +$442K | 0.01% | 1820 |
|
|
2020
Q1 | – | Sell |
-2,793
| Closed | -$24K | – | 2558 |
|
|
2019
Q4 | $24K | Buy |
+2,793
| New | +$24K | ﹤0.01% | 2334 |
|
|
2018
Q2 | – | Sell |
-10,863
| Closed | -$243K | – | 2126 |
|
|
2018
Q1 | $243K | Buy |
+10,863
| New | +$243K | 0.01% | 1278 |
|